1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Fluoxetine Market Size Growth Rate by Type (2020-2025)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Oral Solution
1.4 Market Segment by Application
1.4.1 Global Fluoxetine Market Share by Application (2020-2025)
1.4.2 Depression
1.4.3 Obsessive-compulsive disorder
1.4.4 Panic disorder
1.4.5 Bulimia nervosa
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Fluoxetine Production Value 2015-2025
2.1.2 Global Fluoxetine Production 2015-2025
2.1.3 Global Fluoxetine Capacity 2015-2025
2.1.4 Global Fluoxetine Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Fluoxetine Market Size CAGR of Key Regions
2.2.2 Global Fluoxetine Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Fluoxetine Capacity by Manufacturers
3.1.2 Global Fluoxetine Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Fluoxetine Revenue by Manufacturers (2015-2019)
3.2.2 Fluoxetine Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Fluoxetine Market Concentration Ratio (CR5 and HHI)
3.3 Fluoxetine Price by Manufacturers
3.4 Key Manufacturers Fluoxetine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Fluoxetine Market
3.6 Key Manufacturers Fluoxetine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Tablets Production and Production Value (2015-2019)
4.1.2 Capsules Production and Production Value (2015-2019)
4.1.3 Oral Solution Production and Production Value (2015-2019)
4.2 Global Fluoxetine Production Market Share by Type
4.3 Global Fluoxetine Production Value Market Share by Type
4.4 Fluoxetine Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Fluoxetine Consumption by Application
6 Production by Regions
6.1 Global Fluoxetine Production (History Data) by Regions 2015-2019
6.2 Global Fluoxetine Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Fluoxetine Production Growth Rate 2015-2019
6.3.2 United States Fluoxetine Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Fluoxetine Import & Export
6.4 European Union
6.4.1 European Union Fluoxetine Production Growth Rate 2015-2019
6.4.2 European Union Fluoxetine Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Fluoxetine Import & Export
6.5 China
6.5.1 China Fluoxetine Production Growth Rate 2015-2019
6.5.2 China Fluoxetine Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Fluoxetine Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Fluoxetine Consumption by Regions
7.1 Global Fluoxetine Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Fluoxetine Consumption by Type
7.2.2 United States Fluoxetine Consumption by Application
7.3 European Union
7.3.1 European Union Fluoxetine Consumption by Type
7.3.2 European Union Fluoxetine Consumption by Application
7.4 China
7.4.1 China Fluoxetine Consumption by Type
7.4.2 China Fluoxetine Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Fluoxetine Consumption by Type
7.5.2 Rest of World Fluoxetine Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Teva
8.1.1 Teva Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Fluoxetine
8.1.4 Fluoxetine Product Introduction
8.1.5 Teva Recent Development
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Fluoxetine
8.2.4 Fluoxetine Product Introduction
8.2.5 Sun Pharmaceutical Recent Development
8.3 Sandoz
8.3.1 Sandoz Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Fluoxetine
8.3.4 Fluoxetine Product Introduction
8.3.5 Sandoz Recent Development
8.4 Mylan
8.4.1 Mylan Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Fluoxetine
8.4.4 Fluoxetine Product Introduction
8.4.5 Mylan Recent Development
8.5 Wockhardt
8.5.1 Wockhardt Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Fluoxetine
8.5.4 Fluoxetine Product Introduction
8.5.5 Wockhardt Recent Development
8.6 Dr.Reddy\'s Laboratories
8.6.1 Dr.Reddy\'s Laboratories Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Fluoxetine
8.6.4 Fluoxetine Product Introduction
8.6.5 Dr.Reddy\'s Laboratories Recent Development
8.7 Pharmaceutical Associates Inc.
8.7.1 Pharmaceutical Associates Inc. Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Fluoxetine
8.7.4 Fluoxetine Product Introduction
8.7.5 Pharmaceutical Associates Inc. Recent Development
8.8 Lannett Company
8.8.1 Lannett Company Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Fluoxetine
8.8.4 Fluoxetine Product Introduction
8.8.5 Lannett Company Recent Development
8.9 Aurobindo Pharma
8.9.1 Aurobindo Pharma Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Fluoxetine
8.9.4 Fluoxetine Product Introduction
8.9.5 Aurobindo Pharma Recent Development
8.10 Alembic Pharmaceuticals
8.10.1 Alembic Pharmaceuticals Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Fluoxetine
8.10.4 Fluoxetine Product Introduction
8.10.5 Alembic Pharmaceuticals Recent Development
8.11 Alvogen
8.12 Torrent Pharmaceuticals
8.13 Suzhou YUSHI Pharmaceutical
8.14 Changzhou Siyao Pharmaceutical
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Fluoxetine Capacity, Production Forecast 2020-2025
9.1.2 Global Fluoxetine Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Fluoxetine Production and Value Forecast by Regions 2020-2025
9.2.2 Global Fluoxetine Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Fluoxetine Production Forecast by Type
9.7.2 Global Fluoxetine Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Fluoxetine Sales Channels
10.2.2 Fluoxetine Distributors
10.3 Fluoxetine Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
